Drug and Therapeutics Bulletin 1995;33:81-86; doi:10.1136/dtb.1995.331181
Copyright © 1995 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

The drug treatment of patients with schizophrenia

Relevant BNF section: 4.2

Patients with schizophrenia are managed more and more in the community, with care that demands close collaboration between community mental health teams and general practitioners.1 Treatment with antipsychotic drugs is one essential part of management, which should also include social and psychological support for the patient and carers. The drugs are given both to control acute psychotic symptoms and, in the long term, to prevent relapse. Once started, treatment may be continued lifelong, so it is essential that the diagnosis is established beyond reasonable doubt. In this article we review the drug treatment of schizophrenia.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1995 BMJ Publishing Group Ltd.